인간 신장암 Caki세포에서 dicumarol에 의한 PMA 매개 matrix metalloproteinase-9의 발현 억제 효과

DOI QR코드

DOI QR Code

박은정;권택규
Park, Eun Jung;Kwon, Taeg Kyu

  • 투고 : 2016.01.23
  • 심사 : 2016.02.17
  • 발행 : 2016.02.25

초록

Dicumarol는 전동싸리 식물에서 추출한 coumarin 유도체로 vitamin K 의존적으로 항응고 작용를 한다. 그러나, dicumarol에 의한 MMP-9의 발현 및 활성화 조절에 대한 연구는 수행되지 않았다. 본 연구에서 dicumarol이 인간 신장암 Caki세포에서 PMA 매개의 MMP-9의 발현과 활성화를 조절 할 수 있는지 확인하였다. Dicumarol는 PMA유도 MMP-9의 활성을 억제하였고, MMP-9의 mRNA RT-PCR 및 promoter assay를 통하여 전사단계에서 조절됨을 확인하였다. Dicumarol에 의한 MMP-9 발현 조절에 NF-κB와 AP1 전사인자의 전사 활성 저해에 의하여 야기됨을 확인하였다. NQO1 siRNA를 이용한 knock-down 실험에서 dicumarol이 PMA유도의 MMP-9 활성 억제에 NQO1의 관련성을 확인 할 수 없었다. Dicumarol는 PMA에 의한 세포이동 및 침윤을 억제하였는데, 이러한 현상은 MMP-9의 발현 및 활성을 조절함으로써 일어날 수 있음을 확인하였다.

키워드

Caki cells;Dicumarol;Matrix metalloproteinase-9;NF-κB;NQO1 (NAD(P)H quinone oxidoreductase1)

참고문헌

  1. Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French, D. L. and Quigley, J. P. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 274, 13066-13076. https://doi.org/10.1074/jbc.274.19.13066
  2. Soreide, K., Janssen, E. A., Korner, H. and Baak, J. P. 2006. Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis. J. Pathol. 209, 147-156. https://doi.org/10.1002/path.1999
  3. Uzui, H., Harpf, A., Liu, M., Doherty, T. M., Shukla, A. and Chai, N. 2002. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 106, 3024-3030. https://doi.org/10.1161/01.CIR.0000041433.94868.12
  4. Vasiliou, V., Ross, D. and Nebert, D. W. 2006. Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum. Genomics 2, 329-335. https://doi.org/10.1186/1479-7364-2-5-329
  5. Visse, R. and Nagase, H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839. https://doi.org/10.1161/01.RES.0000070112.80711.3D
  6. Woo, J. H., Lim, J. H., Kim, Y. H., Suh, S. I., Min, D. S., Chang, J. S., Lee, Y. H., Park, J. W. and Kwon, T. K. 2004. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23, 1845-1853. https://doi.org/10.1038/sj.onc.1207307
  7. Kato, Y., Yamashita, T. and Ishikawa, M. 2002. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol. Rep. 9, 565-569.
  8. Lambert, E., Dasse, E., Haye, B. and Petitfrere, E. 2004. TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 49, 187-198. https://doi.org/10.1016/j.critrevonc.2003.09.008
  9. Lee, S. O., Chang, Y. C., Whang, K., Kim, C. H. and Lee, I. S. 2007. Role of NAD(P)H:quinone oxidoreductase 1 on tumor necrosis factor-alpha-induced migration of human vascular smooth muscle cells. Cardiovasc. Res. 76, 331-339. https://doi.org/10.1016/j.cardiores.2007.06.030
  10. Ling, H., Zhang, Y., Ng, K. Y. and Chew, E. H. 2011. Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res. Treat. 126, 609-620. https://doi.org/10.1007/s10549-010-0929-5
  11. Matsunaga, Y., Koda, M. and Murawaki, Y. 2004. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue. Res. Commun. Mol. Pathol. Pharmacol. 115, 143-150.
  12. Nolan, K. A., Scott, K. A., Barnes, J., Doncaster, J., Whitehead, R. C. and Stratford, I. J. 2010. Pharmacological inhibitors of NAD(P)Hquinone oxidoreductase, NQO1: structure /activity relationships and functional activity in tumour cells, Biochem.Pharmacol. 80, 977-981. https://doi.org/10.1016/j.bcp.2010.06.024
  13. Park, E. J., Choi, K. S. and Kwon, T. K. 2011. β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells. Chem. Biol. Interact. 189, 37-44. https://doi.org/10.1016/j.cbi.2010.10.013
  14. Park, E. J., Min, K. J., Choi, K. S. and Kwon, T. K. 2014. Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner. Exp. Cell Res. 323, 144-154. https://doi.org/10.1016/j.yexcr.2014.01.009
  15. Ahn, K. S., Sethi, G., Jain, A. K., Jaiswal, A. K. and Aggarwal, B. B. 2006. Genetic deletion of NAD(P)H:quinone oxidoreductase1 abrogates activation of nuclear factor-kappa B, Ikappa B alpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis. J. Biol. Chem. 281, 19798-19808. https://doi.org/10.1074/jbc.M601162200
  16. Amalinei, C., Caruntu, I. D. and Balan, R. A. 2007. Biology of metalloproteinases. Rom. J. Morphol. Embryol. 48, 323-334.
  17. Asher, G., Dym, O., Tsvetkov, P., Adler, J. and Shaul, Y. 2006. The crystal structure of NAD(P)H quinone oxidoreductase1in complex with its potent inhibitor dicoumarol, Biochemistry 45, 6372-6378. https://doi.org/10.1021/bi0600087
  18. Cullen, J. J., Hinkhouse, M. M., Grady, M., Gaut, A.W., Liu, J., Zhang, Y. P., Weydert, C. J., Domann, F. E. and Oberley, L.W. 2003. Dicumarol inhibition of NADPH:quinone oxidoreductase 1 induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism. Cancer Res. 63, 5513-5520.
  19. Festuccia, C., Giunciuglio, D., Guerra, F., Villanova, I., Angelucci, A., Manduca, P., Teti, A., Albini, A. and Bologna, M. 1999. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion. Oncol. Res. 11, 17-31.
  20. Hansen, M. B., Nielsen, S. E. and Berg, K. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203-210. https://doi.org/10.1016/0022-1759(89)90397-9
  21. Jung, J. S., Jung, K., Kim, D. H. and Kim, H. S. 2012. Selective inhibition of MMP-9 gene expression by mangiferin in PMA-stimulated human astroglioma cells: involvement of PI3K/Akt and MAPK signaling pathways. Pharmacol. Res. 66, 95-103. https://doi.org/10.1016/j.phrs.2012.02.013
  22. Abdelmohsen, K., Stuhlmann, D., Daubrawa, F. and Klotz, L. O. 2005. Dicumarol is a potent reversible inhibitor of gap junctional intercellular communication. Arch. Biochem. Biophys. 434, 241-247. https://doi.org/10.1016/j.abb.2004.11.002